Research Article

Factors Affecting Hypertension in the Adult Population of the Marmara Region, Turkey: A Descriptive Field Study

Table 2

Medications used, risk factors, organ involvement, and laboratory findings for patients with hypertension.

n%

If taking medication; diuretic
No1.23867.3
Yes60232.7

If taking medication; adrenergic antagonist
No1.45979.3
Yes38120.7

If taking medication; renin-angiotensin system etkileyen ilaç
No57631.3
Yes1.26468.7

If taking medication; vascular smooth muscle
No1.31871.6
Yes52228.4

If taking medication; new drug being developed
No1.83999.9
Yes10.1

Risk factors; age (male 45 and female over 65)
No1.32156.1
Yes1.03243.9

Risk factors; family history
No1.21951.8
Yes1.13448.2

Risk factors; smoking
No1.97483.9
Yes37916.1

Risk factors; diabetes mellitus
No1.66170.6
Yes69229.4

Risk factors; hyperlipidemia
No1.81577.1
Yes53822.9

Organ involvement; retinopathy
No1.07694.9
Yes585.1

Organ involvement; nephropathy
No1.06894.2
Yes665.8

Organ involvement; left ventricular hypertrophy
No1.08395.5
Yes514.5

Organ involvement; no
No77268.1
Yes36231.9

Organ involvement; unknown
No51045.0
Yes62455.0

nMean ± SDMedian(Min/max)P. (25/75)P. (5/95)
Triglyceride (mg/dL)1.868157.67 ± 98.51138.00(1/1651)(101/188)(64/310)
Total chol (mg/dL)1.883210.59 ± 48.82208.00(12/800)(179/239)(137/290)
HDL chol (mg/dL)1.86051.47 ± 15.0749.00(4/173)(42/58)(32/80)
LDL chol (mg/dL)1.800130.54 ± 39.68128.50(12/326)(104.5/152)(69.5/199)
Glucose (mg/dL)1.928114.72 ± 39.17103.00(11/440)(93/120)(82/190)
Urea (mg/dL)2.09738.17 ± 28.6131.00(2.14/335.98)(23/43)(10/92.02)
Creatinine (mg/dL)1.9251.17 ± 04.260.81(0.14/85)(0.69/0.97)(0.55/1.4)
GFR (ml/dk)1.67091.61 ± 38.6190.80(0.28/275.7)(69/110.67)(30.663/159.48)

P.: percentile, min: minimum, max: maximum, SD: standard deviation, total chol: total cholesterol, HDL chol: high-density lipoprotein cholesterol, LDL chol: low-density lipoprotein cholesterol, GFR: glomerular filtration rate.